Gujarat Ambuja Exports
- P/E
- 16.77
Key Fundamentals
MicrocapConsumer GoodsFMCGPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 12.50%
- Debt to Equity
- 0.13
- EPS (TTM)
- ₹9.07
- Book Value
- ₹78.27
- Market Cap
- —
- P/E (TTM)
- 16.77
- P/B
- 1.94
- ROE
- 9.72%
- Dividend Yield
- 0.20%
- EBITDA
- ₹574 Cr
- 52W High
- ₹184.99
- 52W Low
- ₹102.05
- Day Range
- ₹146.30 – ₹152.80
- Volume
- 2,74,438
Peer Comparison
Fast Moving Consumer Goods › FMCG › Agricultural Products › Other Agricultural Products
| ₹410.10 | 22.24 | ₹14,281 Cr | 2.91 | 0.73% | 14.70% | 17.60% | ₹11,633 Cr | ₹640 Cr | |
| ₹408.65 | 12.33 | ₹9,318 Cr | 1.50 | 1.12% | 11.70% | 15.20% | ₹6,009 Cr | ₹758 Cr | |
| ₹152.09 | 16.77 | ₹6,847 Cr | 1.94 | 0.20% | 9.72% | 12.50% | ₹6,032 Cr | ₹416 Cr | |
| ₹680.25 | 14.02 | ₹3,469 Cr | 1.73 | 0.75% | 15.00% | 15.80% | ₹1,279 Cr | ₹249 Cr | |
| ₹369.45 | 20.27 | ₹3,167 Cr | 1.96 | 0.00% | 8.38% | 10.40% | ₹2,050 Cr | ₹159 Cr | |
| ₹222.57 | 15.79 | ₹2,241 Cr | 2.33 | 0.00% | 15.80% | 15.70% | ₹2,627 Cr | ₹132 Cr | |
| ₹92.98 | 23.84 | ₹1,926 Cr | 3.21 | 0.48% | 14.20% | 14.00% | ₹1,869 Cr | ₹77 Cr | |
| Median 7 companies | ₹369.45 | 16.77 | ₹3,469 Cr | 1.96 | 0.48% | 14.20% | 15.20% | ₹2,627 Cr | ₹249 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 65
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 55
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 77
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 82
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 49
- Average
- Trend strength, vol-adjusted 12% weight
- Ownership
- 62
- Good
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
3- The company has delivered a poor sales growth of 4.01% over past five years.
- Company has a low return on equity of 10.4% over last 3 years.
- Dividend payout has been low at 3.06% of profits over last 3 years
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 7 | 2 |
| Oscillators | Bearish | 2 | 7 | 0 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 46.32
- Neutral
- MACD (12,26,9)
- −4.99
- Bearish
- SMA (50)
- 162.10
- Bearish
- SMA (200)
- 153.97
- Bearish
As of
Analyst Rating
1 of 1 analyst rates Buy, 0 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +7.67% |
|---|---|
| 5Y | +4.02% |
| 3Y | +5.28% |
| 1Y | +24.19% |
| TTM | +25.30% |
Net profit
| 10Y | +11.32% |
|---|---|
| 5Y | −2.10% |
| 3Y | −2.70% |
| 1Y | +22.09% |
| TTM | +75.53% |
Operating cash flow
| 10Y | +5.38% |
|---|---|
| 5Y | −5.21% |
| 3Y | −1.83% |
| 1Y | −33.14% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +1.30 pp |
|---|---|
| 5Y | −3.20 pp |
| 3Y | −1.53 pp |
| 1Y | −0.52 pp |
| TTM | +1.86 pp |
Revenue by year
| Mar 2014 | ₹3,092 Cr |
|---|---|
| Mar 2015 | ₹2,531 Cr |
| Mar 2016 | ₹2,736 Cr |
| Mar 2020 | ₹3,817 Cr |
| Mar 2021 | ₹4,705 Cr |
| Mar 2022 | ₹4,670 Cr |
| Mar 2023 | ₹4,909 Cr |
| Mar 2024 | ₹4,927 Cr |
| Mar 2025 | ₹4,613 Cr |
| Mar 2026 | ₹5,729 Cr |
Net profit by year
| Mar 2014 | ₹111 Cr |
|---|---|
| Mar 2015 | ₹84.00 Cr |
| Mar 2016 | ₹104 Cr |
| Mar 2020 | ₹146 Cr |
| Mar 2021 | ₹338 Cr |
| Mar 2022 | ₹475 Cr |
| Mar 2023 | ₹330 Cr |
| Mar 2024 | ₹346 Cr |
| Mar 2025 | ₹249 Cr |
| Mar 2026 | ₹304 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Gujarat Ambuja Exports Ltd is an agro-processing and maize starch derivatives company with a market cap of ₹8,046 Cr, trading at a PE of 26x. FY25 standalone revenue declined to ₹4,696 Cr from ₹5,071 Cr in FY24, and net profit fell to ₹251 Cr from ₹346 Cr, reflecting margin pressure from commodity volatility and weak export demand in its maize segment.
- Strong long-term stock CAGR of 24% over 10 years, indicating sustained wealth creation for long-term holders
- TTM sales growth of 24% and TTM profit growth of 24% suggest a recent recovery in operational momentum
- Low debt-to-equity ratio of 0.13x with a current ratio of 3.19, indicating a strong balance sheet and comfortable liquidity
- Healthy interest coverage ratio of ~21x, reflecting minimal financial stress from debt servicing (finance costs only ₹17 Cr on ₹4,696 Cr revenue)
- Dominant market position in Indian maize processing segment with diversified product portfolio (starch, liquid glucose, dextrose syrup, high maltose corn syrup, soya derivatives, cotton yarn)
- Stock price appreciated 57% over the last 1 year, reflecting renewed investor confidence
- 10-year compounded profit growth of 12% shows ability to grow earnings over full business cycles despite interim volatility
- FY25 standalone net profit declined 28% YoY to ₹251 Cr from ₹346 Cr in FY24, indicating significant earnings deterioration
- Poor 5-year compounded sales growth of just 4%, well below inflation, reflecting structural growth challenges
- Low 3-year ROE of only 10.4%, suggesting sub-optimal capital efficiency for shareholders
- Dividend payout of just 3.06% of profits over last 3 years with a yield of only 0.14%, offering negligible income to shareholders
- FY25 revenue fell 7.4% YoY to ₹4,696 Cr from ₹5,071 Cr, with CARE Ratings citing decline in export demand and domestic oversupply in maize processing
- 3-year compounded profit growth is negative at -2%, indicating earnings have stagnated over a medium-term horizon
- Operating margins vulnerable to agro-commodity price volatility and foreign exchange fluctuations as flagged by credit rating agencies
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: GAEL delivered a standout Q1FY27 with 171% profit growth and 23.5% revenue expansion, led by a dominant Maize Processing Division. No visible headwinds emerged from this reporting cycle. The trend is clearly improving, with strong margin expansion suggesting operational leverage is kicking in. Sustainability of maize segment margins into subsequent quarters will be the key monitorable.
- Net profit surges 171% YoY Aug 1
Standalone net profit jumped 171% YoY to ₹176.93 crore in Q1FY27, signaling strong operational performance across divisions.
- Revenue grows 23.5% YoY Aug 1
Q1FY27 revenue rose 23.5% to ₹1,594.27 crore, driven primarily by the Maize Processing Division.
- Maize segment profits spike Aug 1
Maize Processing Division segment profits jumped to ₹190.41 crore in Q1FY27, indicating strong margin expansion in the core business.
- Q1 results approved by board Aug 1
Board approved Q1FY27 results on August 1, 2026, following review by auditors Kantilal Patel & Co. Routine corporate governance disclosure.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,163 | 1,116 | 1,302 | 1,346 | 1,090 | 1,125 | 1,131 | 1,267 | 1,291 | 1,487 | 1,484 | 1,467 | 1,594 | 1,451 |
| Expenses | 1,061 | 1,012 | 1,176 | 1,235 | 985 | 1,015 | 1,008 | 1,204 | 1,195 | 1,411 | 1,385 | 1,272 | 1,362 | 1,253 |
| Operating Profit | 102 | 103 | 126 | 111 | 106 | 110 | 123 | 62 | 96 | 76 | 99 | 195 | 232 | 197 |
| OPM % | 9% | 9% | 10% | 8% | 10% | 10% | 11% | 4.9% | 7% | 5% | 7% | 13% | 15% | 14% |
| Other Income | 27 | 42 | 39 | 37 | 29 | 20 | 9 | 25 | 30 | 19 | 28 | 25.26 | 39 | 17 |
| Interest | 6 | 6 | 3 | 3 | 3 | 4 | 3 | 6 | 5 | 9 | 6 | 7 | 2 | 3 |
| Depreciation | 30 | 30 | 30 | 30 | 31 | 31 | 32 | 32 | 35 | 35 | 33 | 34 | 33 | 34 |
| PBT | 92 | 109 | 131 | 115 | 100 | 94 | 97 | 49 | 86 | 51 | 88 | 180 | 235 | 177 |
| Tax % | 23% | 24% | 23% | 21% | 24% | 26% | 27% | 35% | 24% | 25% | 25% | 25% | 25% | 26% |
| Net Profit | 71 | 83 | 101 | 91 | 77 | 69 | 71 | 32 | 65 | 38 | 66 | 135 | 177 | 132 |
| EPS (₹) | 1.55 | 1.8 | 2.2 | 1.99 | 1.67 | 1.51 | 1.56 | 0.7 | 1.42 | 0.83 | 1.44 | 2.95 | 3.85 | — |
Sep 2026: from the results filed on 24 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,122 | 3,016 | 3,092 | 2,531 | 2,736 | 3,817 | 4,705 | 4,670 | 4,909 | 4,927 | 4,613 | 5,729 | 6,032 |
| Expenses | 2,016 | 2,821 | 2,897 | 2,367 | 2,549 | 3,527 | 4,171 | 3,983 | 4,433 | 4,484 | 4,211 | 5,261 | 5,429 |
| Operating Profit | 106 | 194 | 195 | 165 | 188 | 289 | 535 | 687 | 476 | 443 | 401 | 468 | 602 |
| OPM % | 5% | 6% | 6% | 6% | 7% | 8% | 11% | 15% | 10% | 9% | 9% | 8% | 10% |
| Other Income | 5 | 9 | 10 | 9 | 10 | 2 | 27 | 54 | 73 | 144 | 82 | 102 | 112 |
| Interest | 21 | 22 | 21 | 15 | 10 | 9 | 6 | 6 | 13 | 18 | 17 | 28 | 24 |
| Depreciation | 30 | 37 | 47 | 61 | 65 | 101 | 103 | 97 | 95 | 121 | 126 | 138 | 136 |
| PBT | 61 | 145 | 137 | 98 | 123 | 181 | 452 | 638 | 441 | 448 | 341 | 404 | 554 |
| Tax % | 18% | 22% | 19% | 14% | 16% | 20% | 25% | 26% | 25% | 23% | 27% | 25% | — |
| Net Profit | 50 | 113 | 111 | 84 | 104 | 146 | 338 | 475 | 330 | 346 | 249 | 304 | 416 |
| EPS (₹) | 0.9 | 2.04 | 2.01 | 1.52 | 1.87 | 3.18 | 7.37 | 10.36 | 7.2 | 7.54 | 5.44 | 6.63 | 9.07 |
| Div. Payout % | 17% | 10% | 9% | 14% | 11% | 8% | 4% | 3% | 5% | 0% | 5% | 5% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 28 | 28 | 28 | 28 | 28 | 23 | 23 | 23 | 23 | 46 | 46 | 46 |
| Reserves | 528 | 628 | 729 | 800 | 889 | 1,304 | 1,634 | 2,095 | 2,411 | 2,723 | 2,956 | 3,249 |
| Borrowings | 361 | 183 | 401 | 309 | 329 | 160 | 163 | 281 | 229 | 199 | 229 | 441 |
| Other Liabilities | 223 | 364 | 154 | 148 | 176 | 250 | 342 | 354 | 289 | 342 | 356 | 424 |
| Total Liabilities | 1,140 | 1,203 | 1,312 | 1,284 | 1,421 | 1,736 | 2,162 | 2,753 | 2,952 | 3,310 | 3,587 | 4,160 |
| Fixed Assets | 289 | 458 | 479 | 543 | 562 | 787 | 731 | 771 | 1,042 | 1,037 | 1,179 | 1,185 |
| CWIP | 169 | 38 | 64 | 63 | 101 | 12 | 106 | 246 | 87 | 153 | 235 | 443 |
| Investments | 44 | 44 | 42 | 52 | 73 | 22 | 180 | 714 | 650 | 840 | 938 | 1,061 |
| Other Assets | 638 | 662 | 727 | 626 | 686 | 915 | 1,146 | 1,022 | 1,172 | 1,280 | 1,234 | 1,472 |
| Total Assets | 1,140 | 1,203 | 1,312 | 1,284 | 1,421 | 1,736 | 2,162 | 2,753 | 2,952 | 3,310 | 3,587 | 4,160 |
Cash Flow
₹ Cr| Particulars | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | −4 | 294 | −120 | 253 | 135 | 241 | 298 | 596 | 241 | 213 | 341 | 228 |
| Investing | −95 | −79 | −73 | −130 | −130 | −60 | −302 | −777 | −72 | −253 | −336 | −401 |
| Financing | 96 | −209 | 187 | −124 | −3 | −97 | 1 | 100 | −76 | −55 | −13 | 176 |
| Net Cash Flow | −2 | 6 | −6 | 0 | 2 | 84 | −3 | −81 | 93 | −95 | −8 | 4 |
| Free Cash Flow | −130 | 208 | −223 | 130 | 18 | 156 | 149 | 312 | 44 | 4 | 47 | −153 |
| CFO/OP | 18 | 165 | −45 | 165 | 82 | 96 | 78 | 111 | 72 | 68 | 107 | 69 |
Ratios
| Particulars | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 30 | 13 | 18 | 16 | 23 | 15 | 17 | 18 | 21 | 24 | 28 | 28 |
| Inventory Days | 79 | 67 | 75 | 82 | 73 | 74 | 77 | 76 | 69 | 81 | 79 | 70 |
| Days Payable | 29 | 40 | 10 | 12 | 14 | 17 | 18 | 21 | 15 | 18 | 14 | 13 |
| Cash Conversion Cycle | 79 | 41 | 83 | 86 | 82 | 72 | 76 | 73 | 75 | 87 | 94 | 84 |
| Working Capital Days | 10 | 14 | 21 | 30 | 29 | 42 | 44 | 31 | 44 | 56 | 56 | 42 |
| ROCE % | 10% | 19% | 15% | 9% | 11% | — | 28% | 30% | 18% | 16% | 11% | 12% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Gujarat Ambuja Exports insights
66 extracted metrics across FY12–FY27.
Documents
- Q1 FY27 concall · Aug 2026PPT
- 6 Oct 2026
- 4 Dec 2025
- 12 Sep 2025
- 6 Aug 2025
- 1 Aug 2025
- General announcements 24 Oct 2026
Frequently Asked Questions about Gujarat Ambuja Exports
What does Gujarat Ambuja Exports Ltd do?
Where is Gujarat Ambuja Exports Ltd (GAEL) listed?
Which sector does Gujarat Ambuja Exports Ltd belong to?
What is the PE ratio of Gujarat Ambuja Exports Ltd?
What is the 52-week high and low of Gujarat Ambuja Exports Ltd?
Does Gujarat Ambuja Exports Ltd pay dividends?
What is the Return on Equity (ROE) of Gujarat Ambuja Exports Ltd?
Company Information
Gujarat Ambuja Exports is engaged in the manufacturing of Corn Starch Derivatives, Soya Derivatives, Feed Ingredients, Cotton Yarn, and Edible Oils. Since its incorporation in 1991, GAEL strives to serve the Food, Pharmaceutical, Feed, and many other industries with a long-term growth strategy in the Agro-Processing sector.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GAEL.md for Gujarat Ambuja Exports Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.